The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Epidemiology of Severe Streptococcus pyogenes Disease in Europe
Open accessAbstract
The past 2 decades have brought worrying increases in severe Streptococcus pyogenes diseases globally. To investigate and compare the epidemiological patterns of these diseases within Europe, data were collected through a European Union FP-5-funded program (Strep-EURO). Prospective population-based surveillance of severe S. pyogenes infection diagnosed during 2003 and 2004 was undertaken in 11 countries across Europe (Cyprus, the Czech Republic, Denmark, Finland, France, Germany, Greece, Italy, Romania, Sweden, and the United Kingdom) using a standardized case definition. A total of 5,522 cases were identified across the 11 countries during this period. Rates of reported infection varied, reaching 3/100,000 population in the northern European countries. Seasonal patterns of infection showed remarkable congruence between countries. The risk of infection was highest among the elderly, and rates were higher in males than in females in most countries. Skin lesions/wounds were the most common predisposing factor, reported in 25% of cases; 21% had no predisposing factors reported. Skin and soft tissue were the most common foci of infection, with 32% of patients having cellulitis and 8% necrotizing fasciitis. The overall 7-day case fatality rate was 19%; it was 44% among patients who developed streptococcal toxic shock syndrome. The findings from Strep-EURO confirm a high incidence of severe S. pyogenes disease in Europe. Furthermore, these results have identified targets for public health intervention, as well as raising awareness of severe S. pyogenes disease across Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO analysis of causes of maternal death: a systematic review
Khan, K. S., Wojdyla, D., Say, L., Gülmezoglu, A. M., & Van Look, P. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68397-9 · Cited by 3,978
The global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998
Pathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261
A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI
Lancefield, R. C. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.57.4.571 · Cited by 1,341
Stevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., & Kaplan, E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210101 · Cited by 1,216
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Self-citationEpidemic influenza and vitamin D
CANNELL, J. J., VIETH, R., UMHAU, J. C., HOLICK, M. F., GRANT, W. B., MADRONICH, S., GARLAND, C. F., & GIOVANNUCCI, E. (2006) · Epidemiology and Infection · doi:10.1017/s0950268806007175 · Cited by 1,034
Bacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851
Invasive Group A Streptococcal Infections in Ontario, Canada
Davies, H. D., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A. E., & Low, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350803 · Cited by 736
Invasive Group A Streptococcus Infections
Stevens, D. L. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.2 · Cited by 710
Resurgence of Acute Rheumatic Fever in the Intermountain Area of the United States
Veasy, L. G., Wiedmeier, S. E., Orsmond, G. S., Ruttenberg, H. D., Boucek, M. M., Roth, S. J., Tait, V. F., Thompson, J. A., Daly, J. A., Kaplan, E. L., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160801 · Cited by 681
Seasonal Variation in Host Susceptibility and Cycles of Certain Infectious Diseases
Dowell, S. F. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010301 · Cited by 650
Singleton, R. J., Hennessy, T. W., Bulkow, L. R., Hammitt, L. L., Zulz, T., Hurlburt, D. A., Butler, J. C., Rudolph, K., & Parkinson, A. (2007) · JAMA · doi:10.1001/jama.297.16.1784 · Cited by 615
Darenberg, J., Ihendyane, N., Sjolin, J., Aufwerber, E., Haidl, S., Follin, P., Andersson, J., Norrby-Teglund, A., & The Streptlg Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/376630 · Cited by 573
Self-citationKaul, R., McGeer, A., Norrby‐Teglund, A., Kotb, M., Schwartz, B., O'Rourke, K., Talbot, J., Low, D. E., & The Canadian Streptococcal Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515199 · Cited by 544
Kaul, R., McGeer, A., Low, D. E., Green, K., Schwartz, B., & Simor, A. E. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00160-5 · Cited by 517
O'Loughlin, R. E., Roberson, A., Cieslak, P. R., Lynfield, R., Gershman, K., Craig, A., Albanese, B. A., Farley, M. M., Barrett, N. L., Spina, N. L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521264 · Cited by 499
Streptococcal Toxic-Shock Syndrome: Spectrum of Disease, Pathogenesis, and New Concepts in Treatment
Stevens, D. L. (1995) · Emerging Infectious Diseases · doi:10.3201/eid0103.950301 · Cited by 471
Semmelweis: the combat against puerperal fever
Adriaanse, A. H., Pel, M., & Bleker, O. P. (2000) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00264-5 · Cited by 415
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements.
Riseman, J., Zamboni, W. A., Curtis, A. B., et al. (1990) · PubMed · Cited by 411
Hoge, C. W. (1993) · JAMA · doi:10.1001/jama.269.3.384 · Cited by 406
PHARMACEUTICAL SOCIETY OF GREAT BRITAIN.
Hill, A. (1930) · The Lancet · doi:10.1016/s0140-6736(00)86391-6 · Cited by 376
Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes
Albrich, W. C., Monnet, D. L., & Harbarth, S. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1003.030252 · Cited by 367
Epidemiology of Invasive Group A Streptococcus Disease in the United States, 1995–1999
O’Brien, K. L., Beall, B., Barrett, N. L., Cieslak, P. R., Reingold, A., Farley, M. M., Danila, R., Zell, E. R., Facklam, R., Schwartz, B., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341409 · Cited by 357
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Alejandria, M. M., Lansang, M. A. D., Dans, L. F., & Mantaring III, J. B. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090 · Cited by 313
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
McNeil, S. A., Halperin, S. A., Langley, J. M., Smith, B., Warren, A., Sharratt, G. P., Baxendale, D. M., Reddish, M. A., Hu, M. C., Stroop, S. D., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444458 · Cited by 305
Aspects of Pathogenesis of Serious Group A Streptococcal Infections in Sweden, 1988-1989
Holm, S. E., Norrby, A., Bergholm, A.-M., & Norgren, M. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.1.31 · Cited by 302
Lipsitch, M. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990304 · Cited by 286
The prevalence of hypovitaminosis D among US adults: data from the NHANES III.
Zadshir, A., Tareen, N. G., Pan, D., Norris, K. C., & Martins, D. (2005) · PubMed · Cited by 280
Invasive Group A Streptococcal Disease: Epidemiology, Pathogenesis and Management
Steer, A. C., Lamagni, T., Curtis, N., & Carapetis, J. R. (2012) · Drugs · doi:10.2165/11634180-000000000-00000 · Cited by 273
Self-citationGroup B streptococcal disease in UK and Irish infants younger than 90 days
Heath, P. T., Balfour, G., Weisner, A. M., Efstratiou, A., Lamagni, T. L., Tighe, H., O'Connell, L. A., Cafferkey, M., Verlander, N. Q., Nicoll, A., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15389-5 · Cited by 269
Self-citationLaupland, K. B., Davies, H. D., Low, D. E., Schwartz, B., Green, K., the Ontario Group A Streptococcal Study Group, & McGeer, A. (2000) · Pediatrics · doi:10.1542/peds.105.5.e60 · Cited by 265
Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991
Demers, B., Simor, A. E., Vellend, H., Schlievert, P. M., Byrne, S., Jamieson, F., Walmsley, S., & Low, D. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.6.792 · Cited by 251
Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features
Chelsom, J., Halstensen, A., Chelsom, J., Haga, T., & Høiby, E. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90629-7 · Cited by 241
Seasonal Patterns of Invasive Pneumococcal Disease
Dowell, S. F., Whitney, C. G., Wright, C., Rose, C. E., & Schuchat, A. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0905.020556 · Cited by 221
Laupland, K. B., Kirkpatrick, A. W., & Delaney, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000295312.13466.1c · Cited by 220
Environmental Risk and Meningitis Epidemics in Africa
Molesworth, A. M., Cuevas, L. E., Connor, S. J., Morse, A. P., & Thomson, M. C. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0910.030182 · Cited by 214
Cockerill, F. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540250046030 · Cited by 201
Molecular and Clinical Characteristics of Invasive Group A Streptococcal Infection in Sweden
Darenberg, J., Luca-Harari, B., Jasir, A., Sandgren, A., Pettersson, H., Schalen, C., Norgren, M., Romanus, V., Norrby-Teglund, A., & Normark, B. H. (2007) · Clinical Infectious Diseases · doi:10.1086/519936 · Cited by 197
Self-citationChanges in the pattern of infection caused by Streptococcus pyogenes
Gaworzewska, E., & Colman, G. (1988) · Epidemiology and Infection · doi:10.1017/s095026880006739x · Cited by 195
Group A Streptococci Among School-Aged Children: Clinical Characteristics and the Carrier State
Martin, J. M., Green, M., Barbadora, K. A., & Wald, E. R. (2004) · Pediatrics · doi:10.1542/peds.2004-0133 · Cited by 193
Kotloff, K. L., Corretti, M., Palmer, K., Campbell, J. D., Reddish, M. A., Hu, M. C., Wasserman, S. S., & Dale, J. B. (2004) · JAMA · doi:10.1001/jama.292.6.709 · Cited by 173
Puerperal pyrexia: a review. Part I
Maharaj, D. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000265998.40912.5e · Cited by 167
Reynolds, R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh232 · Cited by 162
Invasive Group A Streptococcal Disease: Risk Factors for Adults
Factor, S. H., Levine, O. S., Schwartz, B., Harrison, L. H., Farley, M. M., McGeer, A., & Schuchat, A. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.020745 · Cited by 159
The Flesh‐Eating Bacterium: What's Next?
Stevens, D. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/513851 · Cited by 158
The Prevention of Invasive Group A Streptococcal Infections Workshop Participants (2002) · Clinical Infectious Diseases · doi:10.1086/342692 · Cited by 155
Severe Streptococcal Infections in Historical Perspective
Katz, A. R., & Morens, D. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.298 · Cited by 153
Invasive Group A Streptococcal Infections
Holm, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350811 · Cited by 150
SevereStreptococcus pyogenesInfections, United Kingdom, 2003–2004
Lamagni, T. L., Neal, S., Keshishian, C., Alhaddad, N., George, R. C., Duckworth, G. J., Vuopio‐Varkila, J., & Efstratiou, A. (2008) · Emerging infectious diseases · doi:10.3201/eid1402.070888 · Cited by 139
Self-citationPopulation‐Based Surveillance for Postpartum Invasive Group A Streptococcus Infections, 1995–2000
Chuang, I., Beneden, C. V., Beall, B., Schuchat, A., & the Active Bacterial Core Surveillance/Emerging Infections Program Network (2002) · Clinical Infectious Diseases · doi:10.1086/342062 · Cited by 137
Descheemaeker, P. R. M., Chapelle, S., Lammens, C., Hauchecorne, M., Wijdooghe, M., Vandamme, P. A. R., Ieven, M. M., & Goossens, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.2.167 · Cited by 130
Luca-Harari, B., Ekelund, K., van der Linden, M., Staum-Kaltoft, M., Hammerum, A. M., & Jasir, A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01626-07 · Cited by 122
Self-citationInvasive Group A Streptococcal Disease in Metropolitan Atlanta: A Population‐Based Assessment
Zurawski, C. A., Bardsley, M. S., Beall, B., Elliott, J. A., Facklam, R. R., Schwartz, B., & Farley, M. M. (1998) · Clinical Infectious Diseases · doi:10.1086/514632 · Cited by 109
Johnson, D. R., Kaplan, E. L., VanGheem, A., Facklam, R. R., & Beall, B. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46224-0 · Cited by 106
The epidemiology of invasive group A streptococcal disease in Victoria, Australia
O’Grady, K.-A. F., Kelpie, L., Andrews, R. M., Curtis, N. C., Nolan, T. M., Selvaraj, G., Passmore, J. W., Oppedisano, F., Carnie, J. A., & Carapetis, J. R. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01054.x · Cited by 105
Melatonin Mediates Seasonal Changes in Immune Function
Nelson, R. J., & Drazen, D. L. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05405.x · Cited by 102
Laupland, K. B., Ross, T., Church, D. L., & Gregson, D. B. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01345.x · Cited by 100
Carapetis, J. R., WALKER, A. M., Hibble, M., Sriprakash, K. S., & Currie, B. J. (1999) · Epidemiology and Infection · doi:10.1017/s0950268898001952 · Cited by 94
Cantón, R., Loza, E., Morosini, M. I., & Baquero, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf811 · Cited by 92
Risk Factors for Pediatric Invasive Group A Streptococcal Disease
Factor, S. H., Levine, O. S., Harrison, L. H., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1107.040900 · Cited by 88
Ekelund, K., Darenberg, J., Norrby‐Teglund, A., Hoffmann, S., Bang, D., Skinhøj, P., & Konradsen, H. B. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3101-3109.2005 · Cited by 85
Self-citationRogers, S., Commons, R. J., Danchin, M. H., Selvaraj, G., Kelpie, L., Curtis, N. C., Robins-Browne, R. M., & Carapetis, J. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/513875 · Cited by 77
Muotiala, A., Seppälä, H., Huovinen, P., & Vuopio‐Varkila, J. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.2.392 · Cited by 74
Self-citationGordon, K. A., Beach, M. L., Biedenbach, D. J., Jones, R. N., Rhomberg, P. R., & Mutnick, A. H. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00374-7 · Cited by 72
COMMENTARY: Nutritional Rickets in Georgia
Tomashek, K. M., Nesby-O’Dell, S., Scanlon, K. S., Cogswell, M. E., Powell, K. E., Parashar, U. D., Mellinger‐Birdsong, A. K., Grummer‐Strawn, L. M., & Dietz, W. H. (2001) · PEDIATRICS · doi:10.1542/peds.107.4.e45 · Cited by 69
(2004) · PubMed · Cited by 68
Streptococcus pyogenes and the Toxic Shock Syndrome
Hřı́balová, V. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-772_2 · Cited by 61
Svensson, N. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655400459504 · Cited by 58
Monteros, L. E. E. D. L., Li, Z., Barreto, D. G., Jaimes, E. C., Rodrı́guez, R. S., Sakota, V., Facklam, R. R., & Beall, B. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.373-378.2003 · Cited by 55
Group A Streptococcus Epidemiology and Vaccine Implications
Cohen‐Poradosu, R., & Kasper, D. L. (2007) · Clinical Infectious Diseases · doi:10.1086/521263 · Cited by 54
Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002.
Griffiths, C., Lamagni, T. L., Crowcroft, N. S., Duckworth, G. J., & Rooney, C. (2004) · PubMed · Cited by 54
Self-citationBen‐Abraham, R., Keller, N., Vered, R., Harel, R., Barzilay, Z., & Paret, G. (2002) · Infection · doi:10.1007/s15010-002-1182-6 · Cited by 51
Melo‐Cristino, J., Fernandes, M. L., & PORTUGUESE SURVEILLANCE GROUP FOR THE STUDY OF RESPIRATORY PATHOGENS (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.219 · Cited by 46
Group A Streptococcal Infections in Injection Drug Users in Barcelona, Spain
Sierra, J. M., Sánchez, F., Castro, P., et al. (2006) · Medicine · doi:10.1097/01.md.0000224707.24392.52 · Cited by 40
Ikebe, T., Hirasawa, K., Suzuki, R., Isobe, J., Tanaka, D., Katsukawa, C., Kawahara, R., Tomita, M., Ogata, K., Endoh, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.788-790.2005 · Cited by 38
An outbreak of serious illness and death among injecting drug users in England during 2000
Jones, J. A., Salmon, J. E., Djuretic, T., Nichols, G. L., George, R. C., & Gill, O. N. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-11-978 · Cited by 38
Ikebe, T., Murai, N., ENDO, M., Okuno, R., Murayama, S., Saitoh, K., Yamai, S., SUZUKI, R., Isobe, J., Tanaka, D., et al. (2003) · Epidemiology and Infection · doi:10.1017/s0950268803008331 · Cited by 34
Ikebe, T., HIRASAWA, K., SUZUKI, R., Ohya, H., Isobe, J., Tanaka, D., Katsukawa, C., Kawahara, R., Tomita, M., Ogata, K., et al. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807007984 · Cited by 32
Kozlov, R. S., Bogdanovich, T., Appelbaum, P. C., Ednie, L. M., Stratchounski, L. S., Jacobs, M. R., & Bozdoğan, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2963-2968.2002 · Cited by 32
Raymond, J., Schlegel, L., Garnier, F., & Bouvet, A. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502567 · Cited by 31
Self-citationNavarro, V. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.23.2679 · Cited by 24
Streptococcal Pharyngitis in Argentina
Gubbay, L., Ellis, A., Holtmann, G. L., et al. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1825-3_12 · Cited by 2
Cited by
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
“The result is a massive cytokine response by T cells (lymphotoxin- , IL-2, and IFN- ) and antigen-presenting cells (TNF- , IL-1 , and IL-6), which causes widespread tissue damage, disseminated intravascular thrombosis, and organ dysfunction (7, 81, 291, 292).”
BackgroundInfluentialGram-positive toxic shock syndromes
Lappin, E., & Ferguson, A. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70066-0 · Cited by 433
Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005–2012
Nelson, G. E., Pondo, T., Toews, K.-A., Farley, M. M., Lindegren, M. L., Lynfield, R., Aragon, D., Zansky, S. M., Watt, J. P., Cieslak, P. R., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw248 · Cited by 404
Molecular insight into invasive group A streptococcal disease
Cole, J. N., Barnett, T. C., Nizet, V., & Walker, M. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2648 · Cited by 377
Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe
Luca-Harari, B., Darenberg, J., Neal, S., Siljander, T., Strakova, L., Tanna, A., Creti, R., Ekelund, K., Koliou, M., Tassios, P. T., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02155-08 · Cited by 300
Self-citation
Metadata
- Authors
- Lamagni, T. L., Darenberg, J., Luca-Harari, B., Siljander, T., Efstratiou, A., Henriques-Normark, B., Vuopio-Varkila, J., Bouvet, A., Creti, R., Ekelund, K., Koliou, M., Reinert, R. R., Stathi, A., Strakova, L., Ungureanu, V., Schalén, C., & Jasir, A.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2008-07
- Volume
- 46
- Issue
- 7
- Pages
- 2359-2367
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2035194773
- Cited by
- 410
- References
- 83
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.